{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:49:56Z","timestamp":1792147796584,"version":"4.4.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DMB"],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Ocular drug delivery is severely affected by anatomical and physiological ocular barriers,\npreventing drug permeation and therapeutic effects. Uveitis, keratitis, and inflammatory postoperative\nocular complications demand accurate, sustained, and localized therapy. Nonsteroidal\nAnti-inflammatory Drugs (NSAIDs) and Steroidal Anti-inflammatory Drugs (Corticosteroids) are\ncornerstones for managing anterior and posterior ocular inflammation. Their traditional formulations,\nhowever, are flawed, with compromised bioavailability, tear clearance, and systemic toxicity.\nNano-formulations prepared using the latest breakthroughs in nanotechnology have transformed\nophthalmic drug delivery by offering enhanced solubility, prolonged retention time, and extended\ndrug release. Liposomes, nanoemulsions, dendrimers, and polymeric nanoparticle-based nanocarriers\nenhance the therapeutic index of Corticosteroids and NSAIDs by improving penetration across\nocular barriers and reducing dosing intervals at the systemic level. Of particular interest, prodrug\nmedications, such as nepafenac, are metabolized intraocularly and provide greater inhibition of\ncyclooxygenase-2 (COX-2). To this end, biopharmaceutical drug evaluation tools, e.g., in vitro\nmodels of the cornea, pharmacokinetic profiling, and ocular imaging, are of utmost significance for\ndetermining the drug's efficacy and safety. Immunopharmacology, by the design of immunosuppressive\ndrugs such as cyclosporine A, is also another branch of anti-inflammatory therapies, such\nas for chronic ocular surface diseases, such as dry eye. Nano-based and combination corticosteroids\nhave been effective methods for controlled inflammation and synergy. Together with nanotechnology\nand the incorporation of biopharmaceutical screening, the era is opening to a new generation of\nophthalmic anti-inflammatory therapy with lower risk, greater efficacy, and a patient-centered approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0131173853470970260930074014","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:25:31Z","timestamp":1792146331000},"source":"Crossref","is-referenced-by-count":0,"title":["Emerging Trends in Ophthalmic Drug Delivery: Focus on NSAIDs and Corticosteroids"],"prefix":"10.2174","volume":"19","author":[{"given":"Sheetal","family":"Devi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar Deemed to be University, Mullana, Ambala, Yamunanagar, India"},{"name":"Department of Pharmacy, Global Research Institute of Pharmacy, Radaur, Yamunanagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Saini","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar Deemed to be University, Mullana, Ambala, Yamunanagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet","family":"Mehan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar Deemed to be University, Mullana, Ambala, Yamunanagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Dushyant","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Global Research Institute of Pharmacy, Radaur, Yamunanagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Narwal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Global Research Institute of Pharmacy, Radaur, Yamunanagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani K.","family":"Dhingra","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Global Research Institute of Pharmacy, Radaur, Yamunanagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurvirender","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Drug Metabolism and Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0131173853470970260930074014","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/259494\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0131173853470970260930074014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:25:37Z","timestamp":1792146337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/259494\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0131173853470970260930074014","relation":{},"ISSN":["3117-3853"],"issn-type":[{"value":"3117-3853","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,13]]}}}